Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Advances in Therapy|January 19, 2019
Clinical Outcomes, Treatment Patterns, and Health Resource Utilization Among Metastatic Breast Cancer Patients with Germline BRCA1/2 Mutation: A Real-World Retrospective StudyRuben G W Quek, Jack Mardekian
Leukemia & Lymphoma|September 13, 2021
Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020-2025Gena Kanas, Wenzhen Ge, Ruben G W Quek, et al.
Cancer|June 1, 2021
The value of new drugs for advanced prostate cancerDavid H Howard, Ruben G W Quek, Kathleen M Fox, et al.
Journal of Managed Care & Specialty Pharmacy|August 1, 2024
Evolving oncology care management trends in the United States: A survey among health care decision makersGary Oderda, Diana Brixner, Joseph Biskupiak, et al.
BMC Cardiovascular Disorders|January 16, 2016
Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort studyKathleen M Fox, Li Wang, Shravanthi R Gandra, et al.
Therapeutic Innovation & Regulatory Science|August 24, 2023
Aiding the Adoption of Master Protocols by Optimizing Patient EngagementRaymond A Huml, Deborah Collyar, Zoran Antonijevic, et al.
International Journal of Oncology|July 20, 2019
A systematic review of the prevalence of DNA damage response gene mutations in prostate cancerShona H Lang, Stephanie L Swift, Heath White, et al.
BMC Health Services Research|June 25, 2015
Productivity loss and indirect costs associated with cardiovascular events and related clinical proceduresXue Song, Ruben G W Quek, Shravanthi R Gandra, et al.
The American Journal of Cardiology|January 9, 2016
A US Claims-Based Analysis of Real-World Lipid-Lowering Treatment Patterns in Patients With High Cardiovascular Disease Risk or a Previous Coronary EventRuben G W Quek, Kathleen M Fox, Li Wang, et al.
Journal of Clinical Lipidology|February 20, 2016
Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United StatesSudhir K Unni, Ruben G W Quek, Joseph Biskupiak, et al.
Pageof 5